See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Liberation Day
Tariffs
Donald Trump
Trade War
Natural Disasters
Social Media
Stock Markets
Trade
European Union
Baseball
Artificial Intelligence
Nintendo
Published • loading... • Updated

Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research

Summary by ShareTrending
Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aiming to accelerate personalized cancer care SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
Unity DevelopersUnity Developers

AI Helps Fight the War Against Cancer

From reducing false positives to personalizing therapies, artificial intelligence is transforming the fight against cancer.

Read Full Article
ShareTrendingShareTrending

Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research

Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aiming to accelerate personalized cancer care SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,...

Read Full Article
hitconsultant.nethitconsultant.net

NCI Partners With Lunit to Drive AI-Powered Cancer Research

What You Should Know:  – Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced a collaboration with the National Cancer Institute (NCI), part of the U.S. National Institutes of Health (NIH).  – The partnership will focus on exploring innovative applications of AI in cancer research, with the goal of improving personalized cancer care. Focus on Tumor Microenvironment and Immune Phenotyping: The collabora…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

hitconsultant.net broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

Similar News Topics

Artificial Intelligence

Artificial Intelligence

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal